JP2003523377A5 - - Google Patents

Download PDF

Info

Publication number
JP2003523377A5
JP2003523377A5 JP2001561295A JP2001561295A JP2003523377A5 JP 2003523377 A5 JP2003523377 A5 JP 2003523377A5 JP 2001561295 A JP2001561295 A JP 2001561295A JP 2001561295 A JP2001561295 A JP 2001561295A JP 2003523377 A5 JP2003523377 A5 JP 2003523377A5
Authority
JP
Japan
Prior art keywords
composition
drug molecule
lipid
liposome
liposome composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001561295A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003523377A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/005997 external-priority patent/WO2001062228A1/en
Publication of JP2003523377A publication Critical patent/JP2003523377A/ja
Publication of JP2003523377A5 publication Critical patent/JP2003523377A5/ja
Withdrawn legal-status Critical Current

Links

JP2001561295A 2000-02-25 2001-02-26 分子の経皮的又は皮内送達のための方法 Withdrawn JP2003523377A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18491800P 2000-02-25 2000-02-25
US60/184,918 2000-02-25
PCT/US2001/005997 WO2001062228A1 (en) 2000-02-25 2001-02-26 Method for transdermal or intradermal delivery of molecules

Publications (2)

Publication Number Publication Date
JP2003523377A JP2003523377A (ja) 2003-08-05
JP2003523377A5 true JP2003523377A5 (https=) 2008-04-24

Family

ID=22678852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001561295A Withdrawn JP2003523377A (ja) 2000-02-25 2001-02-26 分子の経皮的又は皮内送達のための方法

Country Status (7)

Country Link
US (1) US20020040203A1 (https=)
EP (1) EP1280516A4 (https=)
JP (1) JP2003523377A (https=)
CN (1) CN1406125A (https=)
AU (2) AU4174301A (https=)
CA (1) CA2394088A1 (https=)
WO (1) WO2001062228A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
CN102917690B (zh) 2010-03-19 2016-08-24 麻省理工学院 脂质囊泡组合物和使用方法
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
CN103717249B (zh) 2011-06-15 2017-03-22 克洛恩泰克制药股份公司 注射针和装置
CN102726194B (zh) * 2012-07-10 2013-07-03 浙江省萧山棉麻研究所 一种提高亮叶光萼荷繁殖系数的方法
US20160089545A1 (en) * 2013-09-27 2016-03-31 EP Technologies LLC Methods and apparatus for delivery of molecules across layers of tissue
KR20160058934A (ko) * 2013-09-27 2016-05-25 이피 테크놀로지스, 엘엘씨 조직층을 가로질러 분자를 전달하기 위한 방법 및 장치
US10233419B2 (en) 2016-06-30 2019-03-19 Zymergen Inc. Apparatuses and methods for electroporation
CN111803789A (zh) * 2020-06-28 2020-10-23 王瑾 一种无创伤美唇方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) * 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5976567A (en) * 1995-06-07 1999-11-02 Inex Pharmaceuticals Corp. Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5833647A (en) * 1995-10-10 1998-11-10 The Penn State Research Foundation Hydrogels or lipogels with enhanced mass transfer for transdermal drug delivery
JP2002520101A (ja) * 1998-07-13 2002-07-09 ジェネトロニクス、インコーポレーテッド 電気的に補助される化粧用薬剤の局部送達法および装置

Similar Documents

Publication Publication Date Title
Choi et al. Liposomes and niosomes as topical drug delivery systems
Fang et al. Liposomes as vehicles for enhancing drug delivery via skin routes
Cortesi et al. Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA
KR100507660B1 (ko) 리포좀
EP1764091A3 (en) Improvements in or relating to amphoteric liposomes
JPS6176414A (ja) リポソーム製剤の製法
ES2643938T3 (es) Liposoma transpulmonar para controlar la llegada del fármaco
JP2019023243A5 (https=)
JP2019519568A5 (https=)
ATE79028T1 (de) Nystatin enthaltende liposome.
CA2309727A1 (en) Methods for encapsulating nucleic acids in lipid bilayers
JP2003523377A5 (https=)
CN102223878A (zh) 包含鞘磷脂的脂质体系统
JPH08505882A (ja) リポソーム調製法及び物質のカプセル化方法
CA2748520A1 (en) Pharmaceutical composition containing an anionic drug, and a production method therefor
JP2006509750A5 (https=)
WO2023230587A3 (en) Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
NZ503568A (en) Biphasic lipid vesicle composition for transdermal administration of an immunogen
HUP9903363A2 (hu) Készítmény hatóanyag biológiai határfelületeken történő átjuttatására
WO2001000173A1 (fr) Methode de regulation de la fuite de medicaments encapsules dans des liposomes
Bally et al. Lipid/DNA complexes as an intermediate in the preparation of particles for gene transfer: an alternative to cationic liposome/DNA aggregates
JP2001002592A5 (https=)
Liu et al. Advances in studies of phospholipids as carriers in skin topical application
Kumar et al. Ultra deformable niosomes for improved transdermal drug delivery: The future scenario.
E. McNeil et al. Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies